PRESS RELEASE published on 04/28/2025 at 15:45, 11 months 19 days ago Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House Champions Oncology granted license for radioactive materials in preclinical studies, enhancing capabilities in radiotherapeutics development. CEO Ronnie Morris highlights the importance of this milestone Preclinical Studies Radiotherapeutics Champions Oncology Radioactive Materials Biopharmaceutical Partners
PRESS RELEASE published on 04/28/2025 at 15:28, 11 months 19 days ago HelloFresh SE convenes 2025 Annual General Meeting and proposes candidates for the Supervisory Board HelloFresh SE announces 2025 Annual General Meeting to propose new remuneration system for Management Board and expansion of Supervisory Board with new members Supervisory Board HelloFresh SE New Members Remuneration System 2025 Annual General Meeting
PRESS RELEASE published on 04/28/2025 at 15:25, 11 months 19 days ago audius with organic growth by 7.4% in 2024 / very strong operating cash flow and order backlog Audius reports 7.4% organic growth in 2024 with strong cash flow and order backlog. Revenue reaches EUR 84.2 million, while EBITDA and EBIT remain steady EBITDA Revenue Cash Flow Growth Audius
PRESS RELEASE published on 04/28/2025 at 15:09, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.53% stake in Qualcomm Incorporated. Details of position disclosed in Form 8.3 filing on 25 April 2025 Form 8.3 Position Disclosure Vanguard Group Stake Qualcomm Incorporated
PRESS RELEASE published on 04/28/2025 at 15:09, 11 months 19 days ago Inside Information / Other news releases Vivendi's 2025 AGM held in Paris approves all 27 resolutions including new Supervisory Board members. Ordinary cash dividend of €0.04 per share declared for fiscal year 2024 Shareholders Dividend Supervisory Board Vivendi 2025 AGM
PRESS RELEASE published on 04/28/2025 at 15:08, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 11.33% stake in American Axle & Manufacturing Holdings, Inc. along with recent dealings. Form 8.3 filing Form 8.3 Disclosure Vanguard Group Dealings American Axle
PRESS RELEASE published on 04/28/2025 at 15:08, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.38% interest in Greencore Group plc's 1p ordinary securities as of 25 April 2025 The Vanguard Group, Inc. Disclosure 1p Ordinary Greencore Group Plc 5.38%
PRESS RELEASE published on 04/28/2025 at 15:07, 11 months 19 days ago Form 8.3 - The Vanguard Group, Inc.: Aviva plc The Vanguard Group, Inc. discloses a 5.15% stake in Aviva plc as of 25 April 2025 under Rule 8.3 of the Takeover Code Rule 8.3 Vanguard Group Inc. Takeover Code Stake Disclosure Aviva Plc
PRESS RELEASE published on 04/28/2025 at 14:56, 11 months 19 days ago Petrofac Limited: RESULT OF GENERAL MEETING AND PLAN MEETINGS Petrofac Limited announces strong support for Restructuring Plan at General Meeting and Plan Creditor meetings. Sanction Hearing scheduled for May 2025 General Meeting Petrofac Limited Restructuring Plan Sanction Hearing Plan Creditor Meetings
PRESS RELEASE published on 04/28/2025 at 14:30, 11 months 19 days ago Secarna Pharmaceuticals adds leading expert to Scientific Advisory Board with appointment of Prof. Dr. Vignali Secarna Pharmaceuticals appoints Prof. Dr. Dario Vignali to Scientific Advisory Board, enhancing expertise in oncology research and immunotherapy strategies for solid tumors Scientific Advisory Board Immunotherapy Oncology Research Secarna Pharmaceuticals Prof. Dr. Dario Vignali
Published on 04/18/2026 at 04:00, 6 hours 18 minutes ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 8 hours 18 minutes ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 8 hours 43 minutes ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 9 hours 18 minutes ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 10 hours 18 minutes ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 10 hours 12 minutes ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 20:33, 13 hours 44 minutes ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 14 hours 47 minutes ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 19:29, 14 hours 48 minutes ago EQS-Adhoc: KAP AG: KAP AG: REFINANCING CONCEPT AGREED; TERM OF EXISTING SYNDICATED LOAN EXTENDED BY THREE YEARS
Published on 04/17/2026 at 19:00, 15 hours 18 minutes ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 16 hours 33 minutes ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 15:26, 18 hours 51 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of March 31, 2026
Published on 04/17/2026 at 09:10, 1 day 1 hour ago Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 1 day 16 hours ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
